ARRB1 and Respiratory insufficiency due to muscle weakness: These agonists are reported to produce analgesia with reduced respiratory depression (Manglik et al., 2016; Schmid et al., 2017) and thereby provide pharmacological support for the proposed role of ß-arrestin 2 in OIRD.